Twist Bioscience Corp
- Biological Products, Except Diagnostic Substances
- South San Francisco, California
Compensation history
Top executives at Twist Bioscience Corp received an average of $3M per person in annual compensation from 2017 to 2022.
Average pay of disclosed executives at Twist Bioscience Corp
By year
- 2022
EL$6MEmily M. LeproustChief Executive Officer and Chair of the BoardJT$3MJames M. ThorburnChief Financial OfficerPF$3MPatrick FinnPresident and Chief Operating OfficerWB$3MWilliam BanyaiSenior Vice President of Advanced Development and General Manager of Data StoragePW$2MPatrick WeissConsultant, Former Chief Operating OfficerDC$2MDennis ChoSenior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer- 2021
EL$1MEmily M. LeproustPresident, Chief Executive Officer and ChairPW$786KPatrick WeissChief Operating OfficerJT$772KJames M. ThorburnChief Financial OfficerPF$726KPatrick FinnChief Commercial OfficerWB$628KWilliam BanyaiSenior Vice President of Advanced Development and General Manager of Data Storage
Executives
We found seven executives who work or worked at Twist Bioscience Corp.
Emily Leproust
Twist Bioscience Corp
Chief Executive Officer
James Thorburn
Twist Bioscience Corp
Chief Financial Officer
William Banyai
Twist Bioscience Corp
Senior Vice President of Advanced Development and General Manager of Data Storage
Patrick Finn
Twist Bioscience Corp
Chief Operating Officer
Dennis Cho
Twist Bioscience Corp
General Counsel
Patrick Weiss
Twist Bioscience Corp
Chief Operating Officer
Mark Daniels
Twist Bioscience Corp
Chief Legal Officer
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019
About Twist Bioscience Corp
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address681 Gateway Blvd., South San Francisco, California 94080
- Phone800-719-0671
- Fiscal year endSeptember 30
Source: SEC filings on January 6, 2023, January 4, 2022, January 7, 2021, and June 14, 2019.